| Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
| PLD6 |
phospholipase D family, member 6 |
Mapped by significant region |
|
| GJA1 |
gap junction protein, alpha 1, 43kDa |
Mapped by significant region |
|
| SLC44A1 |
solute carrier family 44, member 1 |
Mapped by CNV; Mapped by significant region |
|
| CYB5B |
cytochrome b5 type B (outer mitochondrial membrane) |
Mapped by CNV |
|
| PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
Mapped by significant region |
|
| NLRX1 |
NLR family member X1 |
Mapped by significant region |
|
| MYO19 |
myosin XIX |
Mapped by CNV |
|
| SPATA19 |
spermatogenesis associated 19 |
Mapped by significant region |
|
| ABCB6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
Mapped by significant region |
IDA[17006453]
|
| OPA1 |
optic atrophy 1 (autosomal dominant) |
Mapped by CNV |
IDA[12504110]
|
| BRI3BP |
BRI3 binding protein |
Mapped by CNV |
|
| PGAM5 |
phosphoglycerate mutase family member 5 |
Mapped by CNV |
|
| CPT1A |
carnitine palmitoyltransferase 1A (liver) |
Mapped by CNV; Mapped by significant region |
|
| MAVS |
mitochondrial antiviral signaling protein |
Mapped by CNV |
IDA[18818105]
|
| BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
| BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
Mapped by CNV |
|
| GPAT2 |
glycerol-3-phosphate acyltransferase 2, mitochondrial |
Mapped by LD-proxy |
|
| SMCR7 |
Smith-Magenis syndrome chromosome region, candidate 7 |
Mapped by significant region |
|